cymserine

butyrylcholinesterase inhibitor; structure in first source

Networked: 4 relevant articles (1 outcomes, 0 trials/studies)

1.	Alzheimer Disease (Alzheimer's Disease) 05/01/2010 - "Selective human butyrylcholinesterase (BChE) inhibitors such as cymserine have shown considerable promise for restoring cognition in Alzheimer's disease. " 09/01/2020 - "Phenserine, posiphen, tolserine and cymserine and its derivatives are experimental Alzheimer's disease drugs that contain a phenyl phenylcarbamate moiety that is responsible for their anti-Alzheimer activities. "
2.	Neuroblastoma 01/01/2000 - "To compare the effects of ChEIs on APP processing, we have tested a series of ChEIs such as tacrine, physostigmine, metrifonate, phenserine and cymserine in cultured human neuroblastoma cells. "
3.	Dementia (Dementias) 01/01/2002 - "Experimental evidence from the use of agents with enhanced selectivity for BuChE (cymserine analogues, MF-8622) and the dual inhibitor of both AChE and BuChE, rivastigmine, indicates potential therapeutic benefits of inhibiting both AChE and BuChE in AD and related dementias. "